JP2004501132A5 - - Google Patents

Download PDF

Info

Publication number
JP2004501132A5
JP2004501132A5 JP2002504212A JP2002504212A JP2004501132A5 JP 2004501132 A5 JP2004501132 A5 JP 2004501132A5 JP 2002504212 A JP2002504212 A JP 2002504212A JP 2002504212 A JP2002504212 A JP 2002504212A JP 2004501132 A5 JP2004501132 A5 JP 2004501132A5
Authority
JP
Japan
Prior art keywords
dichloro
alkyl
acid
alkenyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002504212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004501132A (ja
Filing date
Publication date
Priority claimed from GBGB0015205.8A external-priority patent/GB0015205D0/en
Application filed filed Critical
Publication of JP2004501132A publication Critical patent/JP2004501132A/ja
Publication of JP2004501132A5 publication Critical patent/JP2004501132A5/ja
Withdrawn legal-status Critical Current

Links

JP2002504212A 2000-06-21 2001-06-15 甲状腺受容体リガンド、それらを含む薬学的組成物、および甲状腺ホルモンにより影響を及ぼされる障害の治療におけるそれらの使用 Withdrawn JP2004501132A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015205.8A GB0015205D0 (en) 2000-06-21 2000-06-21 Bioisosteric thyroid receptor ligands and method
PCT/EP2001/006815 WO2001098256A1 (en) 2000-06-21 2001-06-15 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones

Publications (2)

Publication Number Publication Date
JP2004501132A JP2004501132A (ja) 2004-01-15
JP2004501132A5 true JP2004501132A5 (enExample) 2008-07-10

Family

ID=9894112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002504212A Withdrawn JP2004501132A (ja) 2000-06-21 2001-06-15 甲状腺受容体リガンド、それらを含む薬学的組成物、および甲状腺ホルモンにより影響を及ぼされる障害の治療におけるそれらの使用

Country Status (8)

Country Link
US (1) US7199265B2 (enExample)
EP (1) EP1296936A1 (enExample)
JP (1) JP2004501132A (enExample)
KR (1) KR20030058952A (enExample)
AU (1) AU779880B2 (enExample)
CA (1) CA2412161C (enExample)
GB (1) GB0015205D0 (enExample)
WO (1) WO2001098256A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163918B2 (en) * 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US20040242594A1 (en) * 2001-11-17 2004-12-02 Dan Peters Prodrugs of antidepressants and their use for treating depressions
GB0208384D0 (en) * 2002-04-11 2002-05-22 Karobio Ab Novel compounds
US7518033B2 (en) * 2002-08-02 2009-04-14 The General Hospital Corporation Methods for the production of cells and mammals with desired genetic modifications
FR2858232B1 (fr) * 2003-07-29 2006-03-03 Pierre Potier Utilisation d'un derive de biguanide pour proteger la peau des radiations uvb
JP2007512359A (ja) * 2003-11-19 2007-05-17 メタバシス・セラピューティクス・インコーポレイテッド 新規なリン含有甲状腺ホルモン様物質
DE602004011985T2 (de) * 2003-11-25 2009-03-05 Eli Lilly And Co., Indianapolis Modulatoren des peroxisomproliferatoraktivierten rezeptors
WO2005090297A1 (en) * 2004-03-19 2005-09-29 Biotie Therapies Corporation Sulphonamide derivatives
GB0406378D0 (en) * 2004-03-22 2004-04-21 Karobio Ab Novel pharmaceutical compositions
GB0406380D0 (en) * 2004-03-22 2004-04-21 Karobio Ab Novel pharmaceutical compositions
US8188277B2 (en) 2004-08-06 2012-05-29 Otsuka Pharmaceutical Co., Ltd. Aromatic compounds for suppressing the generation of collagen
US20060039890A1 (en) * 2004-08-20 2006-02-23 Renshaw Perry F Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant
BRPI0514815A (pt) * 2004-09-01 2008-06-24 Univ Boston método para tratar um distúrbio de pele hiperproliferativa, e, composição farmacêutica
CA2606499C (en) 2005-05-26 2017-06-13 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
RU2007148927A (ru) * 2005-05-26 2009-07-10 Метабэйзис Терапьютикс, Инк. (Us) Новые тиреомиметики, содержащие фосфиновую кислоту
GB0513692D0 (en) * 2005-07-04 2005-08-10 Karobio Ab Novel pharmaceutical compositions
CA2630468C (en) 2005-12-05 2015-01-20 Otsuka Pharmaceutical Co., Ltd. Medicinal drug
GB0608724D0 (en) 2006-05-03 2006-06-14 Karobio Ab Novel Pharmaceutical Compositions
WO2008024746A1 (en) * 2006-08-21 2008-02-28 Array Biopharma, Inc. 4-substituted phenoxyphenylacetic acid derivatives
UA95978C2 (ru) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Ингибитор активации stat3/5
GB0725214D0 (en) * 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
JP2011088826A (ja) * 2008-01-31 2011-05-06 Astellas Pharma Inc 芳香族カルボン酸化合物
BRPI1015096A2 (pt) * 2009-04-20 2016-05-03 Mitsubishi Tanabe Pharma Corp agonista de receptor beta de hormônio tireoideano
JP6031355B2 (ja) 2009-10-11 2016-11-24 ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー 医療装置のための生体適合性重合体
CA3069030C (en) 2012-02-03 2021-11-16 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
US11472918B2 (en) 2012-02-03 2022-10-18 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
AU2015370426B2 (en) 2014-12-23 2019-09-12 Rutgers, The State University Of New Jersey Biocompatible iodinated diphenol monomers and polymers
US10774030B2 (en) 2014-12-23 2020-09-15 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
WO2018094265A2 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
CN110996966A (zh) 2017-06-05 2020-04-10 维京治疗公司 用于治疗纤维化的组合物
EP3683306A4 (en) 2017-09-14 2021-06-09 Riken METHOD FOR MANUFACTURING RETINAGE TISSUE
KR20200138283A (ko) 2018-03-22 2020-12-09 바이킹 테라퓨틱스 인코포레이티드 결정질 형태, 및 결정질 형태의 화합물을 제조하는 방법
WO2020117962A1 (en) 2018-12-05 2020-06-11 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
CN121081472A (zh) 2018-12-13 2025-12-09 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
MY206063A (en) 2019-03-13 2024-11-27 Riken Method for evaluating quality of transplant neural retina, and transplant neural retina sheet
AU2020267576B2 (en) 2019-05-08 2025-03-13 Aligos Therapeutics, Inc. Modulators of THR-β and methods of use thereof
EP4017875A4 (en) * 2019-08-23 2023-05-03 Terns Pharmaceuticals, Inc. THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
CA3154391A1 (en) 2019-09-12 2021-03-18 Terns Pharmaceuticals, Inc. Thyroid hormone receptor beta agonist compounds
WO2022054924A1 (ja) 2020-09-11 2022-03-17 大日本住友製薬株式会社 移植用組織のための媒体
JPWO2022054925A1 (enExample) 2020-09-11 2022-03-17
TW202233577A (zh) 2020-11-06 2022-09-01 美商艾利格斯醫療公司 羥吲哚及其使用方法
JPWO2023090427A1 (enExample) 2021-11-19 2023-05-25
KR20250166323A (ko) 2023-04-07 2025-11-27 테른스 파마슈티칼스, 인크. 간 장애 또는 심장대사 질환의 치료에 사용하기 위한 thr베타 효현제 및 glp-1r 효현제를 포함하는 조합

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB643089A (en) * 1947-10-23 1950-09-15 Glaxo Lab Ltd Improvements in or relating to the preparation of 2:6-dihalogeno diphenyl ethers
GB642159A (en) * 1947-10-23 1950-08-30 Glaxo Lab Ltd Improvements in or relating to the preparation of diphenyl ethers
US3652665A (en) * 1970-04-20 1972-03-28 Merck & Co Inc Halo-phenoxy salicylic acids
US4465508A (en) * 1979-07-18 1984-08-14 Imperial Chemical Industries Plc Diphenyl ether herbicides
DK0580550T3 (da) 1992-07-21 1998-02-02 Ciba Geigy Ag Oxamidsyrederivater som hypercholesterolæmiske midler
GB9416219D0 (en) * 1994-08-11 1994-10-05 Karobio Ab Receptor ligands
DE19527305A1 (de) * 1995-07-26 1997-01-30 Hoechst Ag Substituierte Zimtsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5883294A (en) 1997-06-18 1999-03-16 The Regeants Of The University Of California Selective thyroid hormone analogs
IL144765A0 (en) * 1999-03-01 2002-06-30 Pfizer Prod Inc Oxamic acids and derivatives as thyroid receptor ligands

Similar Documents

Publication Publication Date Title
JP2004501132A5 (enExample)
EP1379507B1 (en) HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
JP2866744B2 (ja) 眼の炎症障害を処置するための３‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物
JP3778516B2 (ja) 新規なアリールプロピオン酸誘導体、その製造方法及び鎮痛薬としてのその用途
RU2001120701A (ru) Новые лиганды тиреоидных рецепторов
JP5927236B2 (ja) 乾癬を予防または低減する方法
RU2006141416A (ru) Пролекарства леводопа, композиции на их основе и их применения
CA2526534A1 (en) Compounds and methods for delivery of prostacyclin analogs
JPH09512798A (ja) 消炎、鎮痛および抗血栓活性を有するニトロ化合物およびそれらの組成物
US8748485B2 (en) Compound and medical use thereof
JPH0657685B2 (ja) ５α―リダクターゼ阻害活性を有するベンゾイルアミノフェノキシブタン酸誘導体、それらの製造方法およびそれらを含有する薬剤
JP2012131829A (ja) そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用
RU2002101622A (ru) Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом
UA42686C2 (uk) Похідні 3-хінуклідилових ефірів, проміжні сполуки та спосіб одержання 3-хінуклідилових ефірів, фармацевтична композиція, що має антимускаринову дію, та спосіб лікування хронічних обструктивних захворювань дихальних шляхів або астми
JP2003500466A5 (enExample)
EP2265267B1 (en) Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
MXPA02001740A (es) Uso de bis-sulfonamidas para producir medicinas para la profilaxis o tratamiento de hiperlipidemia.
JP2003523993A5 (enExample)
HUP0303399A2 (hu) Foszfodiészteráz IV gátló hatású gyógyászati készítmények előállítására alkalmas vegyületek
EP1644316B1 (en) 2-aminobenzoyl derivatives
RU2005136431A (ru) 4-, 6-или 7-гидроксииндолы с n-оксидными группами и их применение в качестве терапевтических средств
KR980002020A (ko) 오르토-치환된 벤조일구아니딘, 이의 제조방법, 약물 또는 진단제로서의 이의 용도 및 이를 포함하는 약제
JP2003521500A5 (enExample)
JP2008519001A5 (enExample)
EP0244062A2 (en) Use of aryl ethanol amine derivatives in the treatment of atherosclerosis